A number of genetic studies linked FHL1 missense mutations to congenital myopathies previously recognized by particular structural features, including Reducing body myopathy (RBM) and Emery-Dreifuss Muscular Dystrophy (EDMD) (Cowling et al. 2011). This evidence concerns the gene FHL1 and reducing body myopathy.